We are interested in the identification of molecular markers as predictors of disease in newborns. We also focus on clinical testing, development and implementation of molecular screening methods.

We develop viral detection and characterization assays and investigate new molecular chemistries and platforms. Research includes rhinovirus infection in transplant recipients, drug-resistant influenza and adenovirus evolution.

Dr. Styer’s research interests include the development of new molecular diagnostic tests for the detection, quantification, or characterization of bloodborne viruses and the evaluation of FDA approved diagnostic tests and diagnostic testing algorithms.

Screening has uncovered individuals whose sweat chloride values are above normal, but no other CF symptoms are identified. Our aim is to determine if other variants in the CFTR gene, or modifier genes, correlate with these abnormal levels.

We develop analytical methods to identify unknown chemicals in foods and environmental samples including toxic compounds and chemical terrorism agents, thus providing national surveillance of the food supply.